VFEND - Important Safety Information from Pfizer as approved by the Irish Medicines Board
08 November 2010
Important Safety Information communication from Pfizer on the potential risk of squamous cell carcinoma (SCC) associated with long term VFEND therapy
Important Safety Information - VFEND